{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T13:30:00Z","timestamp":1790429400538,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI43866"],"award-info":[{"award-number":["R01-AI43866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI057266"],"award-info":[{"award-number":["U19AI057266"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine: X"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jvacx.2020.100076","type":"journal-article","created":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T22:08:59Z","timestamp":1598566139000},"page":"100076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?"],"prefix":"10.1016","volume":"6","author":[{"given":"Marc","family":"Hellerstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jvacx.2020.100076_b0005","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/icb.2010.155","article-title":"Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines","volume":"89","author":"Ahmed","year":"2011","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.jvacx.2020.100076_b0010","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2020.100076_b0015","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.3201\/eid1310.070576","article-title":"Duration of antibody responses after severe acute respiratory syndrome","volume":"13","author":"Wu","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jvacx.2020.100076_b0020","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1056\/NEJMc070348","article-title":"Disappearance of antibodies to SARS-associated coronavirus after recovery","volume":"357","author":"Cao","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2020.100076_b0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3201\/eid2206.160010","article-title":"Antibody response and disease severity in healthcare worker MERS survivors","volume":"22","author":"Alshukairi","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.jvacx.2020.100076_b0030","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0950268800048019","article-title":"The time course of the immune response to experimental coronavirus infection of man","volume":"105","author":"Callow","year":"1990","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jvacx.2020.100076_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","author":"Long","year":"2020","journal-title":"Nat Med"},{"issue":"17","key":"10.1016\/j.jvacx.2020.100076_b0040","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jvacx.2020.100076_b0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jvacx.2020.100076_b0050","doi-asserted-by":"crossref","unstructured":"Sekine T, Perez-Potti A, Rivera-Ballesteros O, Buggert M. Karolinska COVID-19 Study Group. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 (Preprint) bioRxiv 2020.06.29.174888.","DOI":"10.1101\/2020.06.29.174888"},{"issue":"14","key":"10.1016\/j.jvacx.2020.100076_b0055","doi-asserted-by":"crossref","first-page":"eaan5393","DOI":"10.1126\/sciimmunol.aan5393","article-title":"Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses","volume":"2","author":"Zhao","year":"2017","journal-title":"Sci Immunol"},{"issue":"10","key":"10.1016\/j.jvacx.2020.100076_b0060","first-page":"1172","article-title":"Antispike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"issue":"13","key":"10.1016\/j.jvacx.2020.100076_b0065","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139024","article-title":"IL-6 and CD8+ T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19","volume":"5","author":"Luo","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jvacx.2020.100076_b0070","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.jvacx.2020.100076_b0075","first-page":"ciaa979","article-title":"Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severity","author":"Lynch","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"7809","key":"10.1016\/j.jvacx.2020.100076_b0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jvacx.2020.100076_b0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/jvi.64.3.1407-1409.1990","article-title":"Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization","volume":"64","author":"Vennema","year":"1990","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.jvacx.2020.100076_b0090","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1128\/JVI.78.22.12672-12676.2004","article-title":"Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets","volume":"78","author":"Weingartl","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.jvacx.2020.100076_b0095","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jvacx.2020.100076_b0100","first-page":"ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019","author":"Zhao","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"10223","key":"10.1016\/j.jvacx.2020.100076_b0105","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan","volume":"395","author":"Huang","year":"2020","journal-title":"China Lancet"},{"issue":"23","key":"10.1016\/j.jvacx.2020.100076_b0110","doi-asserted-by":"crossref","first-page":"12201","DOI":"10.1128\/JVI.06048-11","article-title":"A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge","volume":"85","author":"Bolles","year":"2011","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.jvacx.2020.100076_b0115","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","article-title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals","volume":"181","author":"Grifoni","year":"2020","journal-title":"Cell"},{"issue":"48","key":"10.1016\/j.jvacx.2020.100076_b0120","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd2071","article-title":"Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome","volume":"5","author":"Weiskopf","year":"2020","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jvacx.2020.100076_b0125","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.jvacx.2020.100076_b0130","doi-asserted-by":"crossref","first-page":"9318","DOI":"10.1128\/JVI.01049-10","article-title":"T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice","volume":"84","author":"Zhao","year":"2010","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.jvacx.2020.100076_b0135","article-title":"Understanding the T cell immune response in SARS coronavirus infection","volume":"1","author":"Janice Oh","year":"2012","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jvacx.2020.100076_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","author":"Le Bert","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jvacx.2020.100076_b0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41577-020-0333-2","article-title":"SARS-CoV-2-reactive T cells in patients and healthy donors","volume":"20","author":"Pia","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jvacx.2020.100076_b0150","unstructured":"Peng Y, Mentzer AJ, Liu G, et al. Broad and strong memory CD4+and CD8+T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients. Preprint.bioRxiv. 2020;2020.06.05.134551. Published 2020 Jun 8."},{"key":"10.1016\/j.jvacx.2020.100076_b0155","article-title":"The SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severity","author":"Thieme","year":"2020","journal-title":"MedRxiv"},{"issue":"6","key":"10.1016\/j.jvacx.2020.100076_b0160","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.jvacx.2020.100076_b0165","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jvacx.2020.100076_b0170","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jvacx.2020.100076_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","author":"Folegatti","year":"2020","journal-title":"Lancet"},{"issue":"7685","key":"10.1016\/j.jvacx.2020.100076_b0180","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature24633","article-title":"Origin and differentiation of human memory CD8 T cells after vaccination","volume":"552","author":"Akondy","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.jvacx.2020.100076_b0185","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1038\/nprot.2007.420","article-title":"Measurement of cell proliferation by heavy water labeling","volume":"2","author":"Busch","year":"2007","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jvacx.2020.100076_b0190","doi-asserted-by":"crossref","unstructured":"Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man. Flaxman A and Ewer KJ. Vaccine 2018;6:43l.","DOI":"10.3390\/vaccines6030043"},{"key":"10.1016\/j.jvacx.2020.100076_b0195","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - preliminary report","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvacx.2020.100076_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","author":"Mercado","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jvacx.2020.100076_b0205","first-page":"eabc6284","article-title":"DNA vaccine protection against SARS-CoV-2 in rhesus macaques","author":"Yu","year":"2020","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.jvacx.2020.100076_b0210","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMp2005630","article-title":"Developing Covid-19 vaccines at pandemic speed","volume":"382","author":"Lurie","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Vaccine: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136220300231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590136220300231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:04:12Z","timestamp":1762913052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590136220300231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":42,"alternative-id":["S2590136220300231"],"URL":"https:\/\/doi.org\/10.1016\/j.jvacx.2020.100076","relation":{},"ISSN":["2590-1362"],"issn-type":[{"value":"2590-1362","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?","name":"articletitle","label":"Article Title"},{"value":"Vaccine: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvacx.2020.100076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100076"}}